Delivery Order SPE2DR25D3020-SPE2DR26F9P5B
Award Date 12/2/25
Potential Completion Date 12/3/25
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,251.04 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Xcopri 100 mg tablets (30-count package). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 12, 2025, and represents a child delivery order under AmerisourceBergen's larger prime contract vehicle with DLA. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,080.32 on September 2, 2025, for the supply of Xcopri 200 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Xcopri 200 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,684.59. This is a non-set-aside award, indicating the contract was competitively bid. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,413.60 on August 25, 2025, for the supply of Xcopri 200 mg tablets (30-count). The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Xcopri 50 mg tablets (30-count) with a ceiling value of $1,182.13. This firm fixed-price delivery order, set to complete by August 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation, indicating it was competitively awarded through open competition....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a ceiling value of $2,947.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract has an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,964 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xcopri 100 mg tablets (30-count units) on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,732.70 delivery order on July 14, 2025, for the supply of Xcopri 100 mg tablets (30-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion on July 15, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains the capacity...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,916.59 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Xcopri 50 mg tablets (30-count packaging). This firm fixed-price delivery order, which is not a set-aside contract, represents a competitive award under DLA's broader pharmaceutical procurement framework. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 9,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,569.42 on July 28, 2025, for Xcopri 50 mg tablets (30-count supply). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing pharmaceutical supply agreements with DLA. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...